Hologic, Inc. (NASDAQ: HOLX), a leading provider of specialized medical imaging equipment for women's health and general radiographic applications, today announced the launch of a service-oriented extranet site for its subsidiary, Lorad, of Danbury, CT. Lorad develops and manufactures state-of-the-art breast imaging systems to support the early detection of breast cancer. The Lorad site provides electronic ordering capabilities for registered dealers, along with on-line resources for parts identification, technical bulletins, Operator's Manuals, and CME-approved training courses for Lorad equipment. It also provides a forum for e-mail response to non-urgent technical questions.
According to Jack W. Cumming, CEO and President of Hologic, "This site is one of many initiatives we are undertaking to provide the most comprehensive, readily-accessible support possible. The ability to place an order any time of the day or night, and to have on-line access to technical material will greatly facilitate shipment of replacement parts and accessories as well as resolution of routine service issues. This will increase the availability of our field service technicians and engineers for real-time response to more complex issues. We look forward to ongoing enhancements to this site based on input from its users."
Commenting on launch of the site, Pete Kershaw, Vice President & General Manager of Lorad said, "We are pleased to be able to bring this new capability to our dealers. This system was developed internally by Information Systems and Field Service personnel to streamline parts identification, ordering, service, and training processes. As a result of their efforts, we will be able to provide customer support more efficiently and responsively. This extranet site, combined with our 24/7 telephone support services and on-site visits by our technical staff provides a complete range of support services to address any situation."
Hologic, Inc. is dedicated to developing and delivering proprietary X-ray and ultrasound systems that incorporate direct-to-digital radiographic imaging technology for both women's health and general radiographic applications. Hologic's business divisions include Hologic Osteoporosis Assessment, a provider of premier bone densitometry systems, Hologic Radiographic Systems, encompassing general and digital radiography systems, and the wholly-owned subsidiaries: Direct Radiography Corp., a manufacturer of state-of-the-art proprietary flat panel technology called DirectRay®; Fluoroscan Imaging, a manufacturer of, low intensity, real time X-ray imaging devices; and Lorad, specializing in innovative mammography and minimally invasive breast biopsy systems.
Forward-Looking Information Disclaimer
This News Release contains forward-looking information that involves risks and uncertainties, including statements about Hologic's plans, objectives, expectations and intentions. Such statements include, without limitation, statements regarding the anticipated benefits from Hologic's and LORAD's extranet website. These forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. Factors that could cause actual results to materially differ include, without limitation, Hologic's continuing losses and ability to fund those losses as well as other working capital requirements; Hologic's ability to predict accurately the demand for its products and to develop strategies to address its markets successfully; uncertainties inherent in the development of new products and the enhancement of existing products, including technical and regulatory risks, cost overruns and delays; the early stage of market development for digital X-ray products; risks relating to the Company's reliance on a single source of supply for some key components of its products; risks related to ongoing litigation; technical innovations that could render products marketed or under development by Hologic obsolete; competition; and reimbursement policies for the use of Hologic's products. Other factors that could adversely affect Hologic's business and prospects are described in Hologic's filings with the Securities and Exchange Commission. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such statement is based.
MAKE YOUR OPINION COUNT - Click Here
SOURCE: Hologic, Inc.
Contact: Glenn P. Muir, Executive Vice President and CFO, or Marianne E. Ritchie Manager, Investor Relations, of Hologic, Inc., +1-781-999-7300
Web site: http://www.hologic.com/